In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

"Myxoma medusa", an unusual atrial mass: a multimodality imaging approach to the diagnosis

Session Clinical case poster session 1

Speaker Luis Maria Madrona Jimenez

Congress : EuroCMR 2019

  • Topic : imaging
  • Sub-topic : Cardiac Magnetic Resonance: Cardiac Masses
  • Session type : Poster Session
  • FP Number : P129

Authors : LM Madrona-Jimenez (Seville,ES), M Chaparro Munoz (Seville,ES), C Caparros-Escudero (Seville,ES), D Martins De Araujo Romeo (Seville,ES), MJ Valle Caballero (Seville,ES), JM Barquero Aroca (Seville,ES), A Recio Mayoral (Seville,ES), RJ Hidalgo Urbano (Seville,ES)

LM Madrona-Jimenez1 , M Chaparro Munoz1 , C Caparros-Escudero2 , D Martins De Araujo Romeo2 , MJ Valle Caballero1 , JM Barquero Aroca3 , A Recio Mayoral4 , RJ Hidalgo Urbano4 , 1University Hospital of Virgen Macarena, Cardiac Imaging Unit, Cardiology - Seville - Spain , 2University Hospital of Virgen Macarena, Radiology - Seville - Spain , 3University Hospital of Virgen Macarena, Cardiovascular Surgery - Seville - Spain , 4University Hospital of Virgen Macarena, Cardiology - Seville - Spain ,

European Heart Journal - Cardiovascular Imaging ( 2019 ) 20 ( Supplement 2 ), ii75

Introduction: atrial myxomas are the most common primary heart tumors. Diagnosis is usually made by echocardiography, with the usual left atrial location and polypoid round or oval shape. However, sometimes other conditions must be considered in the differential diagnosis of a cardiac mass. 
We present the case of a 62-year-old-woman with intermittent "burning" chest pain without any other symptoms. Physical exam was normal. Initial complementary tests such as electrocardiogram and chest X-ray were normal. Transthoracic echocardiography showed a pediculated mass with "snake-like" motion inside the left atrium and trans-esophageal echocardiogram (TEE) was ordered. 2D and 3D TEE demonstrated a bi-lobulated, 2- fingered and mobile mass attached to the inter-atrial septum. Because de unusual morphology of the mass, atrial myxoma and thrombus-in-transit were proposed as possible diagnoses and anticoagulant therapy was started. Cardiac magnetic resonance was performed to get a better characterization of the tissue and revealed high signal intensity of the mass on T1-T2-weighted images. Late enhancement sequences after gadolinium injection showed hyper-intense heterogeneous mass, consistent with the diagnosis of myxoma and after surgery, pathological examination showed a hypo cellular myxoid matrix rich in proteoglycans with a mucous stroma and groups of cells forming nest and cord confirming the diagnosis.
Conclusion: This case illustrates de usefulness of a multimodality approach for establishing a prompt diagnosis and management of an extremely rare morphology of myxoma named "myxoma medusa".

The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are